[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global MAb Biosimilars Sales Market Report 2017

August 2017 | 111 pages | ID: G6D4452716DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global MAb Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of MAb Biosimilars for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global MAb Biosimilars market competition by top manufacturers/players, with MAb Biosimilars sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Biocon
  • Celltrion
  • Dr. Reddy's Laboratories
  • Hospira
  • 3SBio
  • Accord Healthcare
  • AET Biotech
  • Allergan
  • Alvartis Pharma
  • Amega Biotech
  • Amgen
  • Apotex
  • BioXpress Therapeutics
  • Natco Pharma
  • Sanifo
  • Synthon
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Synthetic chemicls
  • Biopharmaceuticals
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of MAb Biosimilars for each application, including
  • Chronic and autoimmune diseases
  • Oncology
Global MAb Biosimilars Sales Market Report 2017

1 MAB BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of MAb Biosimilars
1.2 Classification of MAb Biosimilars by Product Category
  1.2.1 Global MAb Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global MAb Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic chemicls
  1.2.4 Biopharmaceuticals
  1.2.5 Others
1.3 Global MAb Biosimilars Market by Application/End Users
  1.3.1 Global MAb Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chronic and autoimmune diseases
  1.3.3 Oncology
1.4 Global MAb Biosimilars Market by Region
  1.4.1 Global MAb Biosimilars Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States MAb Biosimilars Status and Prospect (2012-2022)
  1.4.3 China MAb Biosimilars Status and Prospect (2012-2022)
  1.4.4 Europe MAb Biosimilars Status and Prospect (2012-2022)
  1.4.5 Japan MAb Biosimilars Status and Prospect (2012-2022)
  1.4.6 Southeast Asia MAb Biosimilars Status and Prospect (2012-2022)
  1.4.7 India MAb Biosimilars Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of MAb Biosimilars (2012-2022)
  1.5.1 Global MAb Biosimilars Sales and Growth Rate (2012-2022)
  1.5.2 Global MAb Biosimilars Revenue and Growth Rate (2012-2022)

2 GLOBAL MAB BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global MAb Biosimilars Market Competition by Players/Suppliers
  2.1.1 Global MAb Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global MAb Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global MAb Biosimilars (Volume and Value) by Type
  2.2.1 Global MAb Biosimilars Sales and Market Share by Type (2012-2017)
  2.2.2 Global MAb Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Global MAb Biosimilars (Volume and Value) by Region
  2.3.1 Global MAb Biosimilars Sales and Market Share by Region (2012-2017)
  2.3.2 Global MAb Biosimilars Revenue and Market Share by Region (2012-2017)
2.4 Global MAb Biosimilars (Volume) by Application

3 UNITED STATES MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 United States MAb Biosimilars Sales and Value (2012-2017)
  3.1.1 United States MAb Biosimilars Sales and Growth Rate (2012-2017)
  3.1.2 United States MAb Biosimilars Revenue and Growth Rate (2012-2017)
  3.1.3 United States MAb Biosimilars Sales Price Trend (2012-2017)
3.2 United States MAb Biosimilars Sales Volume and Market Share by Players
3.3 United States MAb Biosimilars Sales Volume and Market Share by Type
3.4 United States MAb Biosimilars Sales Volume and Market Share by Application

4 CHINA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 China MAb Biosimilars Sales and Value (2012-2017)
  4.1.1 China MAb Biosimilars Sales and Growth Rate (2012-2017)
  4.1.2 China MAb Biosimilars Revenue and Growth Rate (2012-2017)
  4.1.3 China MAb Biosimilars Sales Price Trend (2012-2017)
4.2 China MAb Biosimilars Sales Volume and Market Share by Players
4.3 China MAb Biosimilars Sales Volume and Market Share by Type
4.4 China MAb Biosimilars Sales Volume and Market Share by Application

5 EUROPE MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe MAb Biosimilars Sales and Value (2012-2017)
  5.1.1 Europe MAb Biosimilars Sales and Growth Rate (2012-2017)
  5.1.2 Europe MAb Biosimilars Revenue and Growth Rate (2012-2017)
  5.1.3 Europe MAb Biosimilars Sales Price Trend (2012-2017)
5.2 Europe MAb Biosimilars Sales Volume and Market Share by Players
5.3 Europe MAb Biosimilars Sales Volume and Market Share by Type
5.4 Europe MAb Biosimilars Sales Volume and Market Share by Application

6 JAPAN MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan MAb Biosimilars Sales and Value (2012-2017)
  6.1.1 Japan MAb Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 Japan MAb Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 Japan MAb Biosimilars Sales Price Trend (2012-2017)
6.2 Japan MAb Biosimilars Sales Volume and Market Share by Players
6.3 Japan MAb Biosimilars Sales Volume and Market Share by Type
6.4 Japan MAb Biosimilars Sales Volume and Market Share by Application

7 SOUTHEAST ASIA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia MAb Biosimilars Sales and Value (2012-2017)
  7.1.1 Southeast Asia MAb Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia MAb Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia MAb Biosimilars Sales Price Trend (2012-2017)
7.2 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Players
7.3 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Type
7.4 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Application

8 INDIA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 India MAb Biosimilars Sales and Value (2012-2017)
  8.1.1 India MAb Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 India MAb Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 India MAb Biosimilars Sales Price Trend (2012-2017)
8.2 India MAb Biosimilars Sales Volume and Market Share by Players
8.3 India MAb Biosimilars Sales Volume and Market Share by Type
8.4 India MAb Biosimilars Sales Volume and Market Share by Application

9 GLOBAL MAB BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Biocon
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 MAb Biosimilars Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Biocon MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Celltrion
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 MAb Biosimilars Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Celltrion MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Dr. Reddy's Laboratories
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 MAb Biosimilars Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Dr. Reddy's Laboratories MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Hospira
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 MAb Biosimilars Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Hospira MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 3SBio
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 MAb Biosimilars Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 3SBio MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Accord Healthcare
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 MAb Biosimilars Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Accord Healthcare MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 AET Biotech
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 MAb Biosimilars Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 AET Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Allergan
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 MAb Biosimilars Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Allergan MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Alvartis Pharma
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 MAb Biosimilars Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Alvartis Pharma MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Amega Biotech
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 MAb Biosimilars Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Amega Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Amgen
9.12 Apotex
9.13 BioXpress Therapeutics
9.14 Natco Pharma
9.15 Sanifo
9.16 Synthon

10 MAB BIOSIMILARS MAUFACTURING COST ANALYSIS

10.1 MAb Biosimilars Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of MAb Biosimilars
10.3 Manufacturing Process Analysis of MAb Biosimilars

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 MAb Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL MAB BIOSIMILARS MARKET FORECAST (2017-2022)

14.1 Global MAb Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global MAb Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global MAb Biosimilars Price and Trend Forecast (2017-2022)
14.2 Global MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global MAb Biosimilars Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global MAb Biosimilars Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global MAb Biosimilars Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global MAb Biosimilars Sales Forecast by Type (2017-2022)
  14.3.2 Global MAb Biosimilars Revenue Forecast by Type (2017-2022)
  14.3.3 Global MAb Biosimilars Price Forecast by Type (2017-2022)
14.4 Global MAb Biosimilars Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of MAb Biosimilars
Figure Global MAb Biosimilars Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global MAb Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic chemicls Product Picture
Figure Biopharmaceuticals Product Picture
Figure Others Product Picture
Figure Global MAb Biosimilars Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of MAb Biosimilars by Application in 2016
Figure Chronic and autoimmune diseases Examples
Figure Oncology Examples
Figure Global MAb Biosimilars Market Size (Million USD) by Regions (2012-2022)
Figure United States MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global MAb Biosimilars Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players MAb Biosimilars Sales Volume (K Units) (2012-2017)
Table Global MAb Biosimilars Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global MAb Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 MAb Biosimilars Sales Share by Players/Suppliers
Figure 2017 MAb Biosimilars Sales Share by Players/Suppliers
Figure Global MAb Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global MAb Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global MAb Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global MAb Biosimilars Revenue Share by Players
Table 2017 Global MAb Biosimilars Revenue Share by Players
Table Global MAb Biosimilars Sales (K Units) and Market Share by Type (2012-2017)
Table Global MAb Biosimilars Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Type (2012-2017)
Figure Global MAb Biosimilars Sales Growth Rate by Type (2012-2017)
Table Global MAb Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global MAb Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Type (2012-2017)
Figure Global MAb Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Global MAb Biosimilars Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global MAb Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Region (2012-2017)
Figure Global MAb Biosimilars Sales Growth Rate by Region in 2016
Table Global MAb Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global MAb Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Region (2012-2017)
Figure Global MAb Biosimilars Revenue Growth Rate by Region in 2016
Table Global MAb Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global MAb Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Region (2012-2017)
Figure Global MAb Biosimilars Revenue Market Share by Region in 2016
Table Global MAb Biosimilars Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global MAb Biosimilars Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Application (2012-2017)
Figure Global MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure United States MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure United States MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table United States MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table United States MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure United States MAb Biosimilars Sales Volume Market Share by Players in 2016
Table United States MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table United States MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure United States MAb Biosimilars Sales Volume Market Share by Type in 2016
Table United States MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table United States MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure United States MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure China MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure China MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure China MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table China MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table China MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure China MAb Biosimilars Sales Volume Market Share by Players in 2016
Table China MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table China MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure China MAb Biosimilars Sales Volume Market Share by Type in 2016
Table China MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table China MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure China MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Europe MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Europe MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Europe MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table Europe MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Europe MAb Biosimilars Sales Volume Market Share by Players in 2016
Table Europe MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Europe MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Europe MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Europe MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table Europe MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Europe MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Japan MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Japan MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table Japan MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Japan MAb Biosimilars Sales Volume Market Share by Players in 2016
Table Japan MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Japan MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Japan MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Japan MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table Japan MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Japan MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Southeast Asia MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Volume Market Share by Players in 2016
Table Southeast Asia MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Southeast Asia MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure India MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure India MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table India MAb Biosimilars Sales Volume (K Units) by Players (2012-2017)
Table India MAb Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure India MAb Biosimilars Sales Volume Market Share by Players in 2016
Table India MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table India MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure India MAb Biosimilars Sales Volume Market Share by Type in 2016
Table India MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table India MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure India MAb Biosimilars Sales Volume Market Share by Application in 2016
Table Biocon Basic Information List
Table Biocon MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Biocon MAb Biosimilars Sales Global Market Share (2012-2017
Figure Biocon MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Celltrion Basic Information List
Table Celltrion MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Celltrion MAb Biosimilars Sales Global Market Share (2012-2017
Figure Celltrion MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Global Market Share (2012-2017
Figure Dr. Reddy's Laboratories MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Hospira MAb Biosimilars Sales Global Market Share (2012-2017
Figure Hospira MAb Biosimilars Revenue Global Market Share (2012-2017)
Table 3SBio Basic Information List
Table 3SBio MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3SBio MAb Biosimilars Sales Growth Rate (2012-2017)
Figure 3SBio MAb Biosimilars Sales Global Market Share (2012-2017
Figure 3SBio MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Accord Healthcare Basic Information List
Table Accord Healthcare MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Global Market Share (2012-2017
Figure Accord Healthcare MAb Biosimilars Revenue Global Market Share (2012-2017)
Table AET Biotech Basic Information List
Table AET Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Growth Rate (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Global Market Share (2012-2017
Figure AET Biotech MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Allergan MAb Biosimilars Sales Global Market Share (2012-2017
Figure Allergan MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Alvartis Pharma Basic Information List
Table Alvartis Pharma MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Global Market Share (2012-2017
Figure Alvartis Pharma MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Amega Biotech Basic Information List
Table Amega Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Global Market Share (2012-2017
Figure Amega Biotech MAb Biosimilars Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Apotex Basic Information List
Table BioXpress Therapeutics Basic Information List
Table Natco Pharma Basic Information List
Table Sanifo Basic Information List
Table Synthon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of MAb Biosimilars
Figure Manufacturing Process Analysis of MAb Biosimilars
Figure MAb Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of MAb Biosimilars Major Players in 2016
Table Major Buyers of MAb Biosimilars
Table Distributors/Traders List
Figure Global MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global MAb Biosimilars Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global MAb Biosimilars Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global MAb Biosimilars Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global MAb Biosimilars Sales Volume Market Share Forecast by Regions in 2022
Table Global MAb Biosimilars Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global MAb Biosimilars Revenue Market Share Forecast by Regions (2017-2022)
Figure Global MAb Biosimilars Revenue Market Share Forecast by Regions in 2022
Figure United States MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Europe MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global MAb Biosimilars Sales (K Units) Forecast by Type (2017-2022)
Figure Global MAb Biosimilars Sales Volume Market Share Forecast by Type (2017-2022)
Table Global MAb Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global MAb Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Global MAb Biosimilars Price (USD/Unit) Forecast by Type (2017-2022)
Table Global MAb Biosimilars Sales (K Units) Forecast by Application (2017-2022)
Figure Global MAb Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories